CyGenica has developed a non-viral, non-toxic platform for intracellular delivery of therapeutics, enhancing the efficacy of drug and antibiotic treatments. This technology addresses the challenge of safe and targeted delivery, improving patient outcomes in both in vitro and in vivo applications.
Funding
$1.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Effective intracellular delivery of therapeutic molecules remains a significant challenge, limiting the efficacy of many drugs and antibiotic treatments due to poor cell penetration and potential toxicity of delivery methods. Current delivery systems often lack the specificity needed to target diseased cells, leading to off-target effects and reduced therapeutic impact.
Solution
CyGenica has developed a non-viral, non-toxic platform technology designed to enhance the intracellular delivery of therapeutics, thereby improving drug and antibiotic efficacy. This platform addresses the limitations of existing delivery methods by providing a safe and targeted approach for transporting therapeutic molecules into cells. The technology aims to improve patient outcomes by increasing the precision and effectiveness of drug delivery in both in vitro and in vivo applications. By overcoming the barriers to intracellular access, CyGenica's platform facilitates the development of more effective treatments for a range of diseases.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and research institutions focused on developing and improving targeted drug delivery systems for various therapeutic applications.
Features
- Non-viral delivery mechanism to minimize immunogenicity and safety concerns
- Non-toxic formulation to reduce off-target effects and improve patient tolerability
- Targeted delivery capabilities to enhance specificity and therapeutic impact
- Enhanced intracellular penetration for improved drug efficacy
- Compatible with a wide range of therapeutic molecules, including drugs and antibiotics